Raymond James & Associates Novo Nordisk A S Call Options Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Jan 16, 2024
SELL
$87.78 - $105.45 $465,234 - $558,885
-5,300 Reduced 60.23%
3,500 $362,000
Q3 2023

Oct 24, 2023
BUY
$90.94 - $199.54 $800,272 - $1.76 Million
8,800 New
8,800 $800,000
Q1 2023

Apr 14, 2023
BUY
$132.34 - $159.14 $860,210 - $1.03 Million
6,500 New
6,500 $1.03 Million

Others Institutions Holding NVO

# of Institutions
1,954
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email